Oramed Pharmaceuticals Inc. (ORMP) financial statements (2021 and earlier)

Company profile

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
NEW YORK, NY 10036
State of Incorp. DE
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1823710775
Cash and cash equivalents151935443
Short-term investments3345332
Restricted cash and investments    000
Deposits current assets11112521132412
Other undisclosed current assets7711000
Total current assets:36413331203117
Noncurrent Assets
Operating lease, right-of-use asset10 
Property, plant and equipment0000000
Long-term investments and receivables4416000
Long-term investments4416000
Prepaid pension costs00
Other undisclosed noncurrent assets0001118129
Total noncurrent assets:5411618129
TOTAL ASSETS:41453547394326
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:3232311
Other undisclosed accounts payable and accrued liabilities3232311
Deferred revenue333
Due to related parties0000 00
Deferred revenue and credits22 
Other undisclosed current liabilities00 2  1
Total current liabilities:6555541
Noncurrent Liabilities
Long-term debt and lease obligation10     
Operating lease, liability10 
Liabilities, other than long-term debt7710014130
Deferred revenue and credits1413 
Deferred revenue6710
Liability for uncertainty in income taxes0000000
Liability, pension and other postretirement and postemployment benefits0000000
Other liabilities000000 
Other undisclosed noncurrent liabilities   11   
Total noncurrent liabilities:77101214130
Total liabilities:1312151619172
Stockholders' equity
Stockholders' equity attributable to parent28331931192625
Common stock0000000
Additional paid in capital12612510099757259
Accumulated other comprehensive income   1001
Accumulated deficit(98)(93)(81)(69)(56)(46)(35)
Total stockholders' equity:28331931192625
TOTAL LIABILITIES AND EQUITY:41453547394326

Income statement (P&L) ($ in millions)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Revenues3332212
Revenue, net222
Cost of revenue  (0) (0)(0) 
Gross profit:3332202
Operating expenses(18)(14)(17)(16)(13)(10)7
Other undisclosed operating income (loss)   0  (2)
Operating income (loss):(15)(12)(15)(14)(11)(10)7
Nonoperating income (expense)001110(0)
Foreign currency transaction gain, before tax0     0
Other nonoperating income (expense)001110(0)
Other undisclosed loss from continuing operations before equity method investments, income taxes(5)      
Income (loss) from continuing operations before equity method investments, income taxes:(20)(12)(14)(13)(10)(10)7
Other undisclosed loss from continuing operations before income taxes      (0)
Income (loss) from continuing operations before income taxes:(20)(12)(14)(13)(10)(10)7
Income tax expense  (0) (0)(1)(0)
Income (loss) before gain (loss) on sale of properties:(20)(12)(14)(13)(10)(11)7
Other undisclosed net income17      
Net income (loss):(3)(12)(14)(13)(10)(11)7
Other undisclosed net loss attributable to parent(17)      
Net income (loss) available to common stockholders, diluted:(20)(12)(14)(13)(10)(11)7

Comprehensive Income ($ in millions)

11/30/2020
TTM
8/31/2020
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Net income (loss):(3)(12)(14)(13)(10)(11)7
Other comprehensive income (loss)   00(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(3)(12)(14)(12)(10)(11)7

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: